LIAISON® T3
Mexico·Clase I·III. DIAGNOSTIC AGENTS·DIASORIN MÉXICO S.A. DE C.V.·Registered April 12, 2019ENSAYO IN VITRO PARA LA DETERMINACIÓN CUANTITATIVA DE LA TRIYODOTIRONINA (T3) TOTAL EN SUERO HUMANO, ASÍ COMO EN PLASMA HEPARINIZADO Y CON EDTA. EL ENSAYO DEBE REALIZARSE EN LA SERIE DE INSTRUMENTOS LIAISON® ANALYZER.
IN VITRO ASSAY FOR THE QUANTITATIVE DETERMINATION OF TOTAL TRIIODOTHYRONINE (T3) IN HUMAN SERUM, AS WELL AS IN HEPARINIZED PLASMA AND WITH EDTA. THE TEST SHOULD BE PERFORMED ON THE LIAISON® ANALYZER INSTRUMENT SERIES.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO IN VITRO PARA LA DETERMINACIÓN CUANTITATIVA DE LA TRIYODOTIRONINA (T3)
- Trade Name (English)
- IN VITRO TEST FOR THE QUANTITATIVE DETERMINATION OF TRIIODOTHYRONINE (T3)
- Analysis ID
- 771R2019 SSA
- Registration Date
- April 12, 2019
- Name (Spanish)
- DIASORIN MÉXICO S.A. DE C.V.
- Name (English)
- DIASORIN MEXICO S.A. DE C.V.
Access comprehensive regulatory information for LIAISON® T3 (LINK® T3) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 771R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on April 12, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.